Lipoprotein-associated phospholipase A2 (Lp-PLA2) in acute coronary syndrome

Lipoprotein-associated phospholipase A2 (Lp-PLA2) in acute coronary syndrome

La phospholipase A2 liée aux lipoprotéines (Lp-PLA2) est une biomarqueur de plusieurs maladies inflammatoires et une niveau sérique élevé est associé à l’instabilité de la plaque artérioscléreuse. Comme son nom l’indique, la Lp-PLA2 est liée aux lipoprotéines plasmatiques (LDL et HDL) et...

Full description

Bibliographic Details
Main Author:	Jabor, Bashar
Other Authors:	Mourad, Walid
Language:	en
Published:	2016
Subjects:	Lp-PLA2 Lipoprotein-associated phospholipase A2 PAF-AH platelet activating factor acetyl hydrolase acute coronary syndrome ACS cardiovascular diseases HDL LDL Phospholipase A2 liée aux lipoprotéines Facteur d’activation des plaquettes acyl hydrolase syndrome coronarien aigu lipoprotéines de haute densité lipoprotéines de basse densité Health Sciences - Medicine and Surgery / Sciences de la santé - Médecine et chirurgie (UMI : 0564)
Online Access:	http://hdl.handle.net/1866/13006

Similar Items

Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro
by: Päivi Turunen, et al.
Published: (2004-09-01)

Structural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometry[S]
by: Jian Cao, et al.
Published: (2013-01-01)

The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA2
by: Constantinos C. Tellis, et al.
Published: (2013-12-01)

The synergistic inhibition of atherogenesis in apoE−/− mice between pravastatin and the sPLA2 inhibitor varespladib (A-002)[S]
by: Zory Shaposhnik, et al.
Published: (2009-04-01)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
by: Yun-jie Yin, et al.
Published: (2020-06-01)

Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus
by: Seema Garg, et al.
Published: (2015-01-01)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
by: Adrianos Nezos, et al.
Published: (2021-06-01)

Lipoprotein-associated phospholipase A2 is increased in patients with impaired bone density
by: Kotaška Karel, et al.
Published: (2014-01-01)

Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress
by: Uwe J.F. Tietge, et al.
Published: (2005-08-01)

Relationship between levels of Lp-PLA2 andpolymorphisms of I198T with coronary heart disease
by: Ling Zhang, et al.
Published: (2016-10-01)

Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers
by: Ostadal Petr, et al.
Published: (2012-11-01)

Switching the substrate specificity of lysoplasmalogen‐specific phospholipase D
by: Takayuki Oyama, et al.
Published: (2021-04-01)

The transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activity
by: Salam Ibrahim, et al.
Published: (2007-07-01)

Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D1
by: Minjoo Kim, et al.
Published: (2014-08-01)

Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet*
by: Amanda Vinson, et al.
Published: (2008-06-01)

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
by: Takeshi Kujiraoka, et al.
Published: (2003-10-01)

Lipoprotein-associated phospholipase A2 in relation to lipid markers: A pan-India correlation study
by: Sandhya Iyer, et al.
Published: (2019-05-01)

Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesiss⃞
by: Jiawei Chen, et al.
Published: (2007-11-01)

Changes of serum lipoprotein phospholipase A2 and CRP levels in patients with chronic periodontitis and hy⁃ perlipidemia after atorvastatin treatment
by: WANG Weilu, et al.
Published: (2017-07-01)

The relationship between dietary patterns and lipoprotein-associated phospholipase A2 levels in adults with cardiovascular risk factors: Tehran Lipid and Glucose Study
by: Seyed Hashem Sezavar Seyedi, et al.
Published: (2020-01-01)

Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis
by: Miguel L. Rufail, et al.
Published: (2005-12-01)

Régulation de la phospholipase A₂ de groupe IVA dans les neutrophiles humains
by: Boulay, Katherine
Published: (2011)

Correlation study of serum Lp-PLA2 and NSE levels with nerve injury degree and lipid metabolism change in patients with acute cerebral infarction
by: Wen-Ting Zheng, et al.
Published: (2017-02-01)

Characterization of oxysterols produced in macrophages and mechanisms of regulation
by: Chen, Yinan
Published: (2016)

GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex
by: Mark A. Deeg, et al.
Published: (2001-03-01)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
by: Yao-dong Ding, et al.
Published: (2020-05-01)

Role of Group 1B Phospholipase A2 in Diet-induced Hyperlipidemia and Selected Disorders of Lipid Metabolism
by: Hollie, Norris I., II
Published: (2013)

Mouse Plasminogen Has Oxidized Phosphatidylcholine Adducts That Are Not Metabolized by Lipoprotein-Associated Phospholipase A2 under Basal Conditions
by: Angelo M. Scanu, et al.
Published: (2010-12-01)

Effects of combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids on lipid profile, lipoprotein-associated phospholipase A2 and thromboxane
by: G. F. Piksina, et al.
Published: (2010-10-01)

The effect of hepatitis C virologic clearance on cardiovascular disease biomarker lipoprotein-associated phospholipase A2 and its relation to serum lipids
by: Amira Isaac, et al.
Published: (2021-05-01)

Importance du récepteur Cluster of differentiation-36 dans le métabolisme des LDL natives et oxydées chez la souris
by: Luangrath, Vilayphone
Published: (2006)

Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
by: Zhao-Hui Hui, et al.
Published: (2018-12-01)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
by: Hao Zhang, et al.
Published: (2020-06-01)

Influence des mécanismes d'endocytose et de la localisation membranaire du récepteur Scavenger de classe B, type I sur la captation sélective des esters de cholestérol des lipoprotéines de faible (LDL) et de haute (HDL) densité
by: Tremblay, Félix
Published: (2010)

Rôle de l'apolipoprotéine C-I sur le métabolisme des lipoprotéines de faible et de haute densité dans les cellules HepG2
by: Krasteva, Veneta
Published: (2008)

Protective role of Lipoprotein-Associated Phospholipase A2 Gene (A379V) Polymorphism against Myocardial Infarction among Egyptians
by: Ola Sharaki, et al.
Published: (2014-01-01)

Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL
by: Waldemar Pruzanski, et al.
Published: (1998-11-01)

Surface Exposure and Packing of Lipoproteins into Outer Membrane Vesicles Are Coupled Processes in Bacteroides
by: Ezequiel Valguarnera, et al.
Published: (2018-11-01)

HDL and electronegative LDL exchange anti- and pro-inflammatory properties
by: Cristina Bancells, et al.
Published: (2010-10-01)

Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of Statins
by: Hayder M. Alkuraishy, et al.
Published: (2018-10-01)